Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/12719725

Download in:

View as

General Info

PMID
12719725